Market Watch: Nutex Health's Earnings Report and Industry Comparison

Nutex Health will release its quarterly earnings report on Thursday, August 14. Analysts expect an EPS of $-5.43. The market awaits the announcement, hoping for news of surpassing estimates and providing upbeat guidance for the next quarter. Shares of Nutex Health are trading at $96.12, up 693.26% over the last 52-week period. The consensus rating for Nutex Health is Buy, with an average one-year price target of $262.5, indicating a potential 173.1% upside.

Nutex Health Inc. (NUTX), a physician-led healthcare services and operations company based in Houston, Texas, is set to release its quarterly earnings report on Thursday, August 14. Analysts anticipate an earnings per share (EPS) of $-1.58, marking a potential rise in revenue and a continuation of the company's growth trajectory [1].

The Houston-based company operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. Nutex Health's PHM segment establishes and operates independent physician associations, offering a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and leases land and hospital buildings, while the Hospital segment develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments [2].

Shares of Nutex Health are currently trading at $96.12, reflecting a significant increase of 693.26% over the last 52-week period. The consensus rating for Nutex Health remains "Buy," with an average one-year price target of $262.5, suggesting a potential 173.1% upside [2].

Analysts expect Nutex Health to report a 132.0% increase in revenue to $176.475 million for the period ending June 30, 2025, compared to $76.08 million a year ago [1]. The market awaits the announcement with anticipation, hoping for news of surpassing estimates and providing upbeat guidance for the next quarter.

In addition to the expected earnings, investors will also be watching for updates on the company's operational performance, strategic initiatives, and future growth prospects. Nutex Health's strong market performance and positive analyst ratings indicate investor confidence in the company's ability to continue delivering value to shareholders.

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U41SO:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/
[2] https://www.marketbeat.com/stocks/NASDAQ/NUTX/